CN1330921A - 由复乳法制造缓释性微球的方法 - Google Patents

由复乳法制造缓释性微球的方法 Download PDF

Info

Publication number
CN1330921A
CN1330921A CN00128884A CN00128884A CN1330921A CN 1330921 A CN1330921 A CN 1330921A CN 00128884 A CN00128884 A CN 00128884A CN 00128884 A CN00128884 A CN 00128884A CN 1330921 A CN1330921 A CN 1330921A
Authority
CN
China
Prior art keywords
emulsion
medicine
microsphere
dispersed
slow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00128884A
Other languages
English (en)
Chinese (zh)
Inventor
朴真圭
朴木淳
金东善
林一镐
智雄吉
明平根
金详凡
郑求英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dong Kook Pharmaceutical Co Ltd
Original Assignee
Dong Kook Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Kook Pharmaceutical Co Ltd filed Critical Dong Kook Pharmaceutical Co Ltd
Publication of CN1330921A publication Critical patent/CN1330921A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B6/00—Heating by electric, magnetic or electromagnetic fields
    • H05B6/64—Heating using microwaves
    • H05B6/80—Apparatus for specific applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02B—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
    • Y02B40/00—Technologies aiming at improving the efficiency of home appliances, e.g. induction cooking or efficient technologies for refrigerators, freezers or dish washers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
CN00128884A 2000-06-28 2000-09-22 由复乳法制造缓释性微球的方法 Pending CN1330921A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000036178A KR100392501B1 (ko) 2000-06-28 2000-06-28 다중 에멀젼법에 의한 서방출성 미립구의 제조방법
KR36178/2000 2000-06-28

Publications (1)

Publication Number Publication Date
CN1330921A true CN1330921A (zh) 2002-01-16

Family

ID=19674602

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00128884A Pending CN1330921A (zh) 2000-06-28 2000-09-22 由复乳法制造缓释性微球的方法

Country Status (16)

Country Link
US (1) US6506410B1 (enExample)
JP (1) JP3641418B2 (enExample)
KR (1) KR100392501B1 (enExample)
CN (1) CN1330921A (enExample)
BR (2) BR0005287A (enExample)
CA (1) CA2317769C (enExample)
DE (1) DE10045374B4 (enExample)
ES (1) ES2185460B1 (enExample)
FR (1) FR2810885B1 (enExample)
GB (1) GB2363986B (enExample)
IN (1) IN189017B (enExample)
IT (1) IT1320273B1 (enExample)
MX (1) MXPA00009408A (enExample)
PL (1) PL348343A1 (enExample)
TR (1) TR200003123A2 (enExample)
ZA (1) ZA200004485B (enExample)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314453C (zh) * 2003-09-25 2007-05-09 中国科学院过程工程研究所 尺寸均一、储存稳定的亲水性药物的复乳载体及其制备方法
WO2010118639A1 (zh) * 2009-04-15 2010-10-21 西安力邦医药科技有限责任公司 氨氯地平微球制剂、其制备方法及应用
CN102083742A (zh) * 2008-05-01 2011-06-01 韩国生命工学研究院 制备均匀尺寸的、含难溶药物的聚合物纳米颗粒的方法
CN1939316B (zh) * 2005-09-28 2012-01-25 中国人民解放军军事医学科学院毒物药物研究所 含阿霉素的微球及其制备方法
CN101528206B (zh) * 2006-05-11 2012-02-15 株式会社Peptron 制备用于缓释的、具有改善的可分散性和可注射性的微球的方法
CN102389756A (zh) * 2011-08-11 2012-03-28 长春金赛药业股份有限公司 复乳法制备微球的方法
CN103211773A (zh) * 2013-04-10 2013-07-24 上海丽珠制药有限公司 一种制备醋酸亮丙瑞林微球的方法
CN103724635A (zh) * 2013-12-06 2014-04-16 中国烟草总公司郑州烟草研究院 一种醋酸纤维素多孔微球的制备方法及其产品
CN103766351A (zh) * 2014-02-14 2014-05-07 国家纳米科学中心 一种纳米农药组合物及其制备方法
CN107412171A (zh) * 2017-04-21 2017-12-01 湖南赛隆药业有限公司 注射用左旋泮托拉唑钠长效微球冻干制剂及其制备方法
CN109316371A (zh) * 2018-09-21 2019-02-12 珀莱雅化妆品股份有限公司 一种芹菜素缓释制剂的制备方法
CN110403736A (zh) * 2019-08-09 2019-11-05 常州市第二人民医院 一种3d打印超多孔钛合金促成骨表面改性方法
CN110787134A (zh) * 2013-05-15 2020-02-14 Cj医药健康株式会社 连续工艺的微球制备方法及由此制备的微球
CN111249524A (zh) * 2020-01-18 2020-06-09 南京医科大学附属口腔医院 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法
CN111658620A (zh) * 2020-04-30 2020-09-15 天津医科大学口腔医院 一种透明质酸-帕瑞昔布plga微球及其制备方法和应用
CN113648283A (zh) * 2021-07-23 2021-11-16 丽水市中心医院 靶向抑制HIF-2α的载药微球制备方法、载药微球及应用

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376242B1 (en) * 1999-09-21 2002-04-23 Emory University Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
DE60138641D1 (de) 2000-10-27 2009-06-18 Baxter Healthcare Sa Herstellung von mikrokügelchen
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
WO2003015750A1 (en) * 2001-08-16 2003-02-27 Baxter International, Inc. Propellant-based microparticle formulations
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
KR100994658B1 (ko) * 2001-12-26 2010-11-16 다케다 야쿠힌 고교 가부시키가이샤 신규 마이크로스피어 및 이들의 제조 방법
WO2004016083A1 (ja) * 2002-08-19 2004-02-26 Nagoya Industrial Science Research Institute 球脊髄性筋萎縮症の病態を再現する非ヒト動物、及び球脊髄性筋萎縮症治療剤
WO2004058844A1 (ja) * 2002-12-25 2004-07-15 E-Tec Co., Ltd. 樹脂微粒子及び樹脂マイクロカプセル、並びにそれらの製造方法
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US20040210118A1 (en) * 2003-04-18 2004-10-21 Michel Letort In situ detection of endoleak and endotension
US20040213767A1 (en) * 2003-04-23 2004-10-28 Marc Hendriks Methods for using adipose-derived cells for healing of aortic aneurysmal tissue
US20040215318A1 (en) * 2003-04-24 2004-10-28 Brian Kwitkin Timed delivery of therapeutics to blood vessels
US7396540B2 (en) * 2003-04-25 2008-07-08 Medtronic Vascular, Inc. In situ blood vessel and aneurysm treatment
US20040254629A1 (en) * 2003-04-25 2004-12-16 Brian Fernandes Methods and apparatus for treatment of aneurysmal tissue
US20040215335A1 (en) * 2003-04-25 2004-10-28 Brin David S. Methods and apparatus for treatment of aneurysmal tissue
US20040215320A1 (en) * 2003-04-25 2004-10-28 James Machek Integral stent graft
US7387645B2 (en) * 2003-04-25 2008-06-17 Medtronic Vascular, Inc. Cellular therapy to heal vascular tissue
SE526027C2 (sv) 2003-05-23 2005-06-14 Gambro Lundia Ab Biokompatibel polymerkomposition, förfarande för beredning av en biokompatibel sampolymerkomposition, artikel med en film av en polymerkomposition och användning av en biokompatibel polymerkomposition för en medicinsk anordning
AU2004241896B2 (en) * 2003-05-23 2008-11-06 Gambro Lundia Ab Biocompatible polymer
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
JP2007531701A (ja) * 2003-07-18 2007-11-08 バクスター・インターナショナル・インコーポレイテッド 制御された相分離により調製される小球状粒子の作製方法、使用および組成物
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20050048127A1 (en) * 2003-07-22 2005-03-03 Larry Brown Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20050043786A1 (en) * 2003-08-18 2005-02-24 Medtronic Ave, Inc. Methods and apparatus for treatment of aneurysmal tissue
US7371228B2 (en) * 2003-09-19 2008-05-13 Medtronic Vascular, Inc. Delivery of therapeutics to treat aneurysms
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
CA2566075A1 (en) 2004-05-12 2005-12-01 Baxter Healthcare S.A. Microspheres comprising protein and showing injectability at high concentrations of said agent
PT1758558E (pt) * 2004-05-12 2013-12-05 Baxter Healthcare Sa Microesferas contendo oligonucleótidos, sua utilização para o fabrico de um medicamento para o tratamento de diabetes do tipo 1
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
EP1765294B1 (en) 2004-05-12 2008-09-24 Baxter International Inc. Nucleic acid microspheres, production and delivery thereof
US8048409B2 (en) * 2004-05-27 2011-11-01 Medtronic Vascular, Inc. Cellular therapy to heal vascular tissue
US20050266043A1 (en) * 2004-05-27 2005-12-01 Medtronic Vascular, Inc. Methods and compounds for treatment of aneurysmal tissue
US20050266042A1 (en) * 2004-05-27 2005-12-01 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysmal tissue
US8541028B2 (en) * 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1812022B1 (en) 2004-09-28 2014-01-15 Atrium Medical Corporation Stand-alone film and methods for making the same
JP2008539259A (ja) * 2005-04-27 2008-11-13 バクスター・インターナショナル・インコーポレイテッド 表面を修飾した微粒子およびその形成方法および使用
EP1933764A2 (en) * 2005-09-02 2008-06-25 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US9278161B2 (en) * 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
WO2007071395A1 (en) * 2005-12-22 2007-06-28 Novartis Ag Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
KR100801194B1 (ko) * 2006-07-14 2008-02-11 한국과학기술원 세포 배양 및 전달용 다공성 생분해성 고분자 미립 담체와그의 제조방법
CN101500616A (zh) 2006-08-04 2009-08-05 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
ES2420479T3 (es) * 2006-08-31 2013-08-23 Sk Chemicals, Co., Ltd. Procedimiento para la producción de microesferas cargadas con fármacos y microesferas cargadas con fármacos producidas mediante el mismo
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
KR100845009B1 (ko) 2007-08-07 2008-07-08 한국생명공학연구원 전하를 띠는 물질이 고착된 다공성 고분자 입자 및 그제조방법
US20110081422A1 (en) * 2007-11-19 2011-04-07 Capsulated Systems Inc. Prolonged release of local anesthetics using microparticles and surgery applications
ES2718612T3 (es) 2007-12-20 2019-07-03 Evonik Corp Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
US8697098B2 (en) * 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
KR100963435B1 (ko) * 2008-06-19 2010-06-17 한국과학기술연구원 서방형 약물전달 및 조직재생용 덮인 다공성 생분해성고분자 미립구의 제조 방법
US8034382B2 (en) * 2008-07-31 2011-10-11 The Board Of Trustees Of The University Of Arkansas Preparation method for biodegradable micro-particles containing drugs
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100131051A1 (en) * 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Systems and Methods for Treatment of Aneurysms Using Zinc Chelator(s)
US20100131001A1 (en) * 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Targeted Drug Delivery for Aneurysm Treatment
US20100152832A1 (en) * 2008-12-12 2010-06-17 Medtronic Vascular, Inc. Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta
EP2389160B1 (en) * 2009-01-23 2017-09-13 Evonik Corporation Continuous double emulsion process for making microparticles
KR101663561B1 (ko) * 2009-02-18 2016-10-10 동국제약 주식회사 서방출성 미립구의 제조방법
KR101105292B1 (ko) * 2009-06-05 2012-01-17 주식회사 리젠 바이오텍 생분해성 고분자 미세입자와 그의 제조방법
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US20110091518A1 (en) * 2009-09-22 2011-04-21 Danielle Biggs Implant devices having varying bioactive agent loading configurations
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
KR101785515B1 (ko) * 2010-11-08 2017-10-16 에스케이케미칼주식회사 올란자핀 함유 고분자 미립구를 유효성분으로 포함하는 약학적 조성물
KR20120048811A (ko) * 2010-11-08 2012-05-16 에스케이케미칼주식회사 아나스트로졸 함유 고분자 미립구를 유효성분으로 포함하는 약학적 조성물
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
KR101952599B1 (ko) 2011-02-25 2019-05-22 사우스다코타주립대학 고분자 컨쥬게이트화된 단백질 마이셀
KR101481859B1 (ko) * 2011-05-20 2015-01-14 에스케이케미칼주식회사 초기 약물 방출이 감소된 고분자 미립자의 제조방법 및 그 방법에 의해 제조된 고분자 미립자
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CN105246500A (zh) 2013-04-05 2016-01-13 克劳迪娅·齐尔贝尔博格 基质金属蛋白酶及其用途
KR101558083B1 (ko) * 2014-04-07 2015-10-07 에스케이케미칼주식회사 약물함유 고분자미립구 제조방법
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
US12370233B2 (en) 2016-08-31 2025-07-29 Mapi Pharma Ltd. Depot systems comprising glatiramer acetate
WO2018178973A1 (en) 2017-03-26 2018-10-04 Mapi Pharma Ltd. Glatiramer depot systems for treating progressive forms of multiple sclerosis
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
US12274787B2 (en) 2018-12-17 2025-04-15 G2Gbio, Inc. Sustained-release injection comprising deslorelin, and preparation method therefor
DE102019126672B4 (de) * 2019-10-02 2021-07-01 Universität Rostock Wirkstoffdepotsystem sowie Kit zur in situ Polymerisation des Wirkstoffdepotsystems
AU2021329820A1 (en) * 2020-08-18 2023-03-09 Oakwood Laboratories, Llc Microsphere formulations comprising ketamine and methods for making and using the same
JP7522402B2 (ja) * 2021-02-26 2024-07-25 熊本県 塩化ビニル系ポリマー粒子の製造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT74025B (de) * 1914-10-16 1917-11-26 Siemens Ag Verfahren und Herstellung einer Mauer im Erdreich.
US4495509A (en) * 1983-06-09 1985-01-22 Moore Business Forms, Inc. Microencapsulation by interchange of multiple emulsions
AR240875A1 (es) * 1984-01-09 1991-03-27 Stauffer Chemical Co Procedimiento para producir capsulas de poliurea de dimensiones multiples que contienen un material inmiscible en agua en su interior y las capsulas resultantes
DE3678308D1 (de) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
JPH04247230A (ja) * 1991-02-01 1992-09-03 Fuji Photo Film Co Ltd マイクロカプセルの製造方法およびそれを用いた感光材料
FR2679788B1 (fr) * 1991-08-02 1994-03-18 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
FR2702391B1 (fr) * 1993-03-11 1995-04-28 Roussel Uclaf Nouvelles émulsions multiples, leur préparation, leur application à la préparation de compositions cosmétiques et ces compositions cosmétiques.
JP3790567B2 (ja) * 1994-09-30 2006-06-28 武田薬品工業株式会社 徐放剤
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
FR2742354B1 (fr) * 1995-12-15 1998-01-23 Oreal Emulsion e/h/e stable contenant un actif cosmetique et/ou dermatologique sensible a l'eau
DE19719297A1 (de) * 1997-05-07 1998-11-12 Henkel Kgaa Verfahren zur Herstellung multipler W/O/W-Emulsionen
US6287587B2 (en) * 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
FR2766737B1 (fr) * 1997-07-31 1999-09-24 Centre Nat Rech Scient Emulsions multiples et leurs applications

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314453C (zh) * 2003-09-25 2007-05-09 中国科学院过程工程研究所 尺寸均一、储存稳定的亲水性药物的复乳载体及其制备方法
CN1939316B (zh) * 2005-09-28 2012-01-25 中国人民解放军军事医学科学院毒物药物研究所 含阿霉素的微球及其制备方法
CN101528206B (zh) * 2006-05-11 2012-02-15 株式会社Peptron 制备用于缓释的、具有改善的可分散性和可注射性的微球的方法
CN102083742A (zh) * 2008-05-01 2011-06-01 韩国生命工学研究院 制备均匀尺寸的、含难溶药物的聚合物纳米颗粒的方法
WO2010118639A1 (zh) * 2009-04-15 2010-10-21 西安力邦医药科技有限责任公司 氨氯地平微球制剂、其制备方法及应用
CN102389756B (zh) * 2011-08-11 2014-01-01 长春金赛药业有限责任公司 复乳法制备微球的方法
CN102389756A (zh) * 2011-08-11 2012-03-28 长春金赛药业股份有限公司 复乳法制备微球的方法
CN103211773B (zh) * 2013-04-10 2014-11-05 上海丽珠制药有限公司 一种制备醋酸亮丙瑞林微球的方法
CN103211773A (zh) * 2013-04-10 2013-07-24 上海丽珠制药有限公司 一种制备醋酸亮丙瑞林微球的方法
CN110787134A (zh) * 2013-05-15 2020-02-14 Cj医药健康株式会社 连续工艺的微球制备方法及由此制备的微球
CN103724635A (zh) * 2013-12-06 2014-04-16 中国烟草总公司郑州烟草研究院 一种醋酸纤维素多孔微球的制备方法及其产品
CN103766351A (zh) * 2014-02-14 2014-05-07 国家纳米科学中心 一种纳米农药组合物及其制备方法
CN103766351B (zh) * 2014-02-14 2015-11-04 国家纳米科学中心 一种纳米农药组合物及其制备方法
CN107412171A (zh) * 2017-04-21 2017-12-01 湖南赛隆药业有限公司 注射用左旋泮托拉唑钠长效微球冻干制剂及其制备方法
CN107412171B (zh) * 2017-04-21 2020-04-17 湖南赛隆药业有限公司 注射用左旋泮托拉唑钠长效微球冻干制剂及其制备方法
CN109316371B (zh) * 2018-09-21 2021-09-03 珀莱雅化妆品股份有限公司 一种芹菜素缓释制剂的制备方法
CN109316371A (zh) * 2018-09-21 2019-02-12 珀莱雅化妆品股份有限公司 一种芹菜素缓释制剂的制备方法
CN110403736A (zh) * 2019-08-09 2019-11-05 常州市第二人民医院 一种3d打印超多孔钛合金促成骨表面改性方法
CN111249524A (zh) * 2020-01-18 2020-06-09 南京医科大学附属口腔医院 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法
CN111658620A (zh) * 2020-04-30 2020-09-15 天津医科大学口腔医院 一种透明质酸-帕瑞昔布plga微球及其制备方法和应用
CN113648283A (zh) * 2021-07-23 2021-11-16 丽水市中心医院 靶向抑制HIF-2α的载药微球制备方法、载药微球及应用
CN113648283B (zh) * 2021-07-23 2023-11-07 丽水市中心医院 靶向抑制HIF-2α的载药微球制备方法、载药微球及应用

Also Published As

Publication number Publication date
TR200003123A2 (tr) 2002-01-21
DE10045374B4 (de) 2007-08-30
BR0005287A (pt) 2002-02-13
JP3641418B2 (ja) 2005-04-20
PL348343A1 (en) 2002-01-02
ITTO20000963A1 (it) 2002-04-13
FR2810885A1 (fr) 2002-01-04
IN189017B (enExample) 2002-12-07
KR20020000698A (ko) 2002-01-05
ITTO20000963A0 (it) 2000-10-13
IT1320273B1 (it) 2003-11-26
US6506410B1 (en) 2003-01-14
DE10045374A1 (de) 2002-01-24
KR100392501B1 (ko) 2003-07-22
ZA200004485B (en) 2001-02-28
ES2185460B1 (es) 2004-06-16
GB0020992D0 (en) 2000-10-11
GB2363986B (en) 2002-12-11
CA2317769C (en) 2005-03-15
JP2002020269A (ja) 2002-01-23
BRPI0005287B1 (pt) 2019-01-22
ES2185460A1 (es) 2003-04-16
CA2317769A1 (en) 2001-12-28
FR2810885B1 (fr) 2003-10-17
MXPA00009408A (es) 2002-03-15
GB2363986A (en) 2002-01-16

Similar Documents

Publication Publication Date Title
CN1330921A (zh) 由复乳法制造缓释性微球的方法
US5288502A (en) Preparation and uses of multi-phase microspheres
Lee et al. Poly (lactic‐co‐glycolic acid) devices: Production and applications for sustained protein delivery
CN1055618C (zh) 缓释微胶囊的制备方法
AU746337B2 (en) Methods for fabricating polymer-based controlled release preparations
DE68904326T3 (de) Physiologisch aktive Substanzen enthaltende Mikrosphären des Polymilchsäuretyps sowie Verfahren zu deren Herstellung.
CN1058864C (zh) 生产微胶囊的方法
CN100518828C (zh) 缓释可生物降解微球体及其制备方法
CH688911A5 (de) Salze von Peptiden mit Polyestern mit endständigen Carboxygruppen.
JP2015227383A (ja) 残留溶媒抽出方法および同により生成される微粒子
CN105106174B (zh) 一种核-壳双层微球及其制备方法
CN1557283A (zh) 三重复合微球制剂及其制备方法
JP2004510723A (ja) 低下した分子量のアミロペクチンをベースとする精製された澱粉を含む制御放出投与のための生物分解性微粒子
US20190380967A1 (en) Preparation of microparticles of an active ingredient
CN1304055C (zh) 尺寸均一的包埋亲水性药物的聚合物微球或微囊载体的制备方法
CN101485627A (zh) 用甘油修饰的水包油－油包固体制备的微球及其制备方法
CN1242750C (zh) 可生物降解的且生物相容的封装有肠炎沙门氏菌的聚合物微球体
CN1732903A (zh) 一种制备缓释微球的方法
CN101511341A (zh) 芳香酶抑制剂的缓释制剂
CN111315365A (zh) 用于通过双乳液技术制备微粒的方法
RU2776379C2 (ru) Способ получения микрочастиц методом двойной эмульсии
Dhanusha et al. Biodegradable polymers for microencapsulation systems
RU2817016C2 (ru) Инъекционные композиции микрочастиц налтрексона длительного действия
KR100202395B1 (ko) 쑥으로부터 추출된 파네실전이 효소저해활성을 갖는 아타노말로이드계 화합물 및 이를 함유하는 조성물
KR20040098746A (ko) 국소 이식형 서방성 제제

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication